Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 838

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 838
---
,800 Series 6 warrants expired. J.During the year 2023, the shareholders’ meeting approved the increase of the Company’s authorized share capital by 50,000,000 Shares, and the capital increase, respectively, so that the authorized share capital of the Company after the capital increase would be USD $4.4 million, divided into 150,000,000 ordinary shares. K.On March 31, 2024, the Company executed a reverse share split at a ratio of 1:10, whereby every ten Shares were consolidated into one ordinary share of NIS 1 par value. The reverse split was also applied to all outstanding convertible securities as of the date of the split. Annex G-36

KADIMASTEM LTD.
NOTES TO FINANCIAL STATEMENTS NOTE 19: — SHARE-BASED PAYMENT A. Expense that was recognized in the financial statements

|                                                             |     | Year ended on December 31, 
                       2024 |     | 2023 |     | 2022 |
|:------------------------------------------------------------|:----|---------------------------:|:----|-----:|:----|-----:|
|                                                             |     |           USD in thousands |     |      |     |      |
| Total expense arising from share-based payment transactions |     |                        208 |     |  149 |     |  235 |

B. Share-based payment plan On March 28, 2022, the Company’s Board of Directors adopted a new global options plan as part of the decision to evaluate the listing of the Company’s shares on the Nasdaq Capital Market. The new plan is intended for the Company’s employees, consultants, service providers, and officers (including directors) (hereinafter, the “New Plan”). The New Plan allows non -marketableoptions (hereinafter, the “Options”) that can be exercised for the Company’s shares to be granted at different exercise prices, as well as restricted share units. The New Plan entered into force on the day of its adoption by the Board of Directors, subject to the required submission to the tax authorities, in accordance with the law. The New Plan will expire at the end of 10 years from the aforementioned date. C.On March 10, 2021, the general meeting of the shareholders approved the grant of Options to the Company’s former Chief Executive Officer (the “CEO”) as part of his employment agreement, as well as to the current chairman of the Company’s Board of